1998 EASD’98 34th Annual Meeting of the European Association for the Study of Diabetes. Barcelona.
1998 The IDA Study Second Workshop. Barcelona.
1998 Cow’s Milk and Diabetes Satellite Symposium to the EASD in Barcelona. Barcelona, Spain.
1998 “Immune Markers for Monitoring the Progression ofAutoimmune Disease” Workshop. Charlottenlund, Denmark.

1998 The ENDIT meeting. Charlottenlund, Denmark.
1998 Insulin dependent Diabetes mellitus in young Adults in Europe (The IDA Study ) Working Group meeting at Vilvorde Kursuscenter. Charlottenlund, Denmark.
1999 EURODIAB Prospective Complications Study Investigator meeting. Hotel Sofitel, Lisbona.
1999 Meeting of the Nutritional prevention of IDDM (TRIGR) project in Budapest, Hungary.
1999 25thAnnual Meeting of the International Society for Pediatric and Adolescent Diabetes. The Netherlands.
1999 The Eurodiab Tiger Final Workshop. De Leeuwenhorst, Noordwijkerhout, Holland.
1999 American Diabetes Association’s 59th Scientific Session.San Diego Marriott
Hotel and Marina and the San Diego Convention Center . San Diego, California.
1999 Meeting ENI. Ospedale Pediatrico Bambino Gesù,Roma.
Research Projects Ongoing or Completed During the Last 3 Years:
- Area Study leader (Sardinia) of the EU – sponsored research Project EURODIAB A (epidemiology) and B (complications).

• EU sponsored TRIGR Project .
• Area study leader (Sardinia) of the EU – sponsored Research Project IDA.

Relevant Publications: (Partial Listing)
1) Toeller M., Buyken A., Heitkamp G., Milne R., Klischan A., Gries FA. and the EURODIAB IDDM Complications Study Group: Repeatability of three-day dietary records in the EURODIAB IDDM Complications Study. European Journal of Clinical Nutrition 1997; 51: 74-80.
2) Songini M.: Diabete di tipo I in Sardegna: il progetto “Hot and Cold Spots”.Aggiornamento Medico 1997; 21, 1: 27-33.
3) Greaves M., Malia RG., Goodfellow K., Mattock M., Stevens LK., Stephenson JM., Fuller JH., and the EURODIAB IDDM Complications Study Group: Fibrinogen and von Willebrand factor in IDDM: relationship to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIABIDDM Complications study. Diabetologia 1997; 40: 698-705.
4) Toeller M., Buyken A., Heitkamp G., Brämswig S., Mann J., Milne R., Gries FA., Keen H., and the EURODIAB IDDM Complications Study Group: Protein intake and urinary albumin excretion rates in the EURODIAB IDDM ComplicationStudy. Diabetologia 1997; 40: 1219-1226.
5) Bottazzo GF., Cossu E., Cirillo R., Loviselli A., Velluzzi F., Mariotti S., Balestrieri A., Delitala G., Sepe V., Songini M. and the Sardinia-IDDM Study Groups: Sardinia: a battlefield approach to type 1 diabetes. Hormone Research 1997; 48 (suppl 4): 64-66.
6) Bottazzo G.F., Loviselli A., Velluzzi F., Mariotti S., Cossu E., Cirillo R., Balestrieri A., Delitala G., Sepe V., Songini M. and the Sardinia-IDDM Study Groups: The ‘Sardinia-IDDM Study’: an attempt to unravel the cause of insulin-dependent diabetes mellitus in one of the countries with the highest incidence of the disease in the world. Ann. Ist. Super. Sanità 1997; 33,n.3: 417-424.
7) M. Songini, L. Bernardinelli, D. Clayton, C. Montomoli, C. Pascutto, M. Ghislandi, D. Fadda, G. F. Bottazzo and the Sardinian IDDM Study Groups: The Sardinian IDDM Study: 1. Epidemiology and geographical distribution of IDDM in Sardinia during 1989 to 1994. Diabetologia 1998; 41,2: 221-227.
8) M. Songini: Epidemiology of IDDM: Recent Advances.Journal of Pediatric Endocrinology & Metabolism 1998;11, suppl. 2: 319-326.
9) D. Serraino, M. Songini, G.F. Bottazzo, P. DePaoli, R. Tedeschi, S. Franceschi: Human Herpesvirus 8 Seroprevalence in Sardinia.Journal of the National Cancer Institute,1998; 90, No. 13.
10) A. E. Buyken, M. Toeller, G. Heitkamp, F. Vitelli, P. Sthele, W. A. Scherbaum, J. H. Fuller and the Eurodiab IDDM Complications Study Group: Relation of fibre intaketo HbA(1c) and the prevalence of severe Ketoacidosis and severe hypoglycaemia. Diabetologia 1998; 41: 882-890.
11) G. Roglic, H.M. Colhoun, L.k. Stevens, H.H. Lemkes, C. Manes, J.H. Fuller, and the EURODIAB IDDM Complications Study Group: Parental History of Hypertensionand Parental History of Diabetes and Microvascular Complications in Insulin-dependent Diabetes Mellitus:
12) Tedeschi R., Caggiari L., Serraino D., Songini M., Bottazzo G.F., Franceschi S., Dillner J., De Paoli P. : Human Herpesvirus 8: Studio di un sistema di indagine sieroepidemiologica. Amcli 1998 XXVII Congresso Nazionale Associazione Microbiologi Clinici Italiani ; CO 9.1 Venezia, Palazzo del Cinema e del Casinò 6-9 ottobre 1998.
13) Tenconi M. T., Devoti G., Piazza M., Nosetti G., Fratino P., Lorini R., Olianas A., Songini M., Bottazzo G. F. : Prevalenza del diabete insulino dipendente tra gli emigranti sardi nella provincia di Pavia. Il Diabete 17° Congresso Nazionale della Società Italiana di Diabetologia (SID) Bologna 13-16 Maggio 1998; (suppl. al no. 1) marzo.
14) M. Songini, I. Vannucci, G. Seu, R. Manca: Progetto Diabete oltre Internet.IlDiabete & l’Infermiere 1998; 6: 198-200.
15) G. Crepaldi et alii: Effects of Lisinopril and Nifedipine on the Progression to Overt Albuminuria in IDDM Patients with Incipient Nephropathy and Normal BloodPressure. Diabetes Care 1998; 21: 104-110.
16) L. Bernardinelli, C. Pascutto, C. Montomoli and J. Komakec, W. Gilks, M. Songini, O. Fiorani, A. Lisa and G. Zei, G. Solinas, G.F. Bottazzo. Bayesan Analysisof Ecological Data for Studyng the Association Between Insulin-Dependent Diabetes Mellitus and Malaria; Capitolo 2 : 29-47 in Statistics for the Environment 4: Pollution Assessment and Control. Edited by V. Barnett, A. Stein and K. Feridun Turkman. 1999 John Wiley & Sons Ltd.
17) Songini M., Loche M., Montomoli C., Bernardinelli L., Bottazzo GF. and the Collaborative Group for IDDM in Sardinia: Geographic Distribution of IDDM (Insulin-Dependent Diabetes Mellitus) 0-29 yrs.: in search for cold and hot spots inthe Island. Abstr. 39, 29th Annual Meeting European Diabetes Epidemiology Study Group, Athens 22-25 may 1999.
18) M. Toeller, A. Buyken, G. Heitkamp, G. de Pergola, F. Giorgino, JH.Fuller and the EURODIAB IDDM Complication Study Group: Fibre intake, serum cholesterol levels and cardiovascolar disease in European individuals with type 1 diabetes. Diabetes Care 1999; 22 (suppl 2): B21-B28.
19) M. Songini: IDDM. Troveremo mai il fattore causale?. Atti, XII Congresso Nazionale (AMD) Chia Domus de Maria 26-29 maggio 1999.
20) A. Loviselli, F. Velluzzi, G. Pinna, G. Secci, A. Pilo, M. Songini, GF. Bottazzo, A. Balestrieri, E. Martino, S. Mariotti and SSI: E’ possibile predire l’IDDM in età scolare nei casi non familiari?. Atti, XII Congresso Nazionale (AMD) Chia Domus de Maria 26-29 maggio 1999.
21) B. Karamanos, M. Porta, M.Songini, Z. Metelko, Z. Kerenyi, G. Tamas, R. Rottiers, L.K. Stevens, J.H.Fuller, and the EURODIAB IDDM Complications Study Group: Different risk factors of microangiopathy in patients with type 1 diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study.Diabetologia 2000; 43: 348-355.
22) EURODIAB ACE Study Group: Variation and trends in incidence of childhood diabetes in Europe. The Lancet 2000; 355: 873-876.
23) M. Songini, M. Locatelli e G.F. Bottazzo per conto dei “IDDM – Sardinia Study Groups”: Recenti acquisizioni sull’eziopatogenesi del diabete di tipo 1. Scripta Medica 2000; 5: 195-212.
24) A. E. Buyken, M. Toeller, G. Heitkamp, K. ‘Irsiglert, C. Hollert, F. Santeusanio, P. Stehle, J. H. Fuller and the EURODIAB IDDM Complications Study Group: Carbohydrate sources and glycaemic controlintype 1 diabetes mellitus.Diabetic Medicine 2000; 17: 351-359.
25) A. Casu, M. Carlini, A. Contu, G. F. Bottazzo, M. Songini: Type 1 Diabetes inSardinia is not linked to nitrate levels in drinking water. Diabetes Care 2000; 23-7: 1043-1044.
26) D. Serraino, G. Ippolito, R.M. Tedeschi, L. Caggiari, M. Songini, M. Cepulic, A. Bonevski, M. Locatelli, S. Franceschi. Prevalence of antibodies to human herpesvirus 8 in children from Sardinia and Croatia. Infection 2000; 28: 336-338.
27) M. Songini, M. Locatelli. Prevalence of diabetic complications in relation to demographics in Europe. Proceedings of the First Meeting of DM-MED. 2000 4-5 june, Tunisia
28) N. Chaturvedi, A. K. Sjoelie, M. Porta, S. J. Aldington, J. H. Fuller, M. Songini, E. M. Kohner, The Eurodiab Prospective Complication Study Group. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes.Diabetes Care 2001; 24 – 2: 284-289.
29) A. E. Buyken, M. Toeller, G Heitkamp, B. Karamanos, R. Rottiers, M. Muggeo, J. H. Fuller M.Sondini et ali (the EURODIAB IDDM Complications Study Group).Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids.Am J Clin Nutr 2001; 73: 574-81.
30) M. B. Mattock, N. Cronint, P. Cavallo-Perin, B. Idzior-Walus, G. Penno, S. Bandinelli, E. Standl, A. Kofinis, J. H. and the Eurodiab IDDM Complications Study Group. Plasma lipids and urinary albumin excretion rate in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.Diabetic Medicine 2001; 18:59-67.
31) D. Serraino, M. Locatelli, M. Songini, R. Cirillo, G.F. Bottazzo, M. Andreoni, S. Franceschi and G. Rezza for the Sardinia Newborn Study Group. Human herpes virus-8 infection among pregnant women and thei children: results from the Sardinia-IDDM Study 2.Int. J. Cancer 2001; 91: 740-741.
32) A. Olivieri, G. Pinna, A. Lai, F. Velluzzi, A. Pilo, F. Atzeni, G. Guaita, I. Pellagra, R. Cirillo, M. Sorcini, S. Carta, G. F. Bottazzo, S. Mariotti, and the Sardinian Newborn Study Group. The Sardinian Autoimmunity Study. 4. Thyroid and islet cell autoantibodiesin Sardinian pregnant women at delivery: A cross-sectional study.J. Endocrinol. Invest. 2001; 24: 570-574.
33) M. Songini, A. Casu, The Sardinian Collaborative Group for Epidemiology of IDDM, I. Ashkenazi and Z. Laron. Seasonality of birth in children (o-14 years) and young adults (0-29 years) with type 1 diabetes mellitus in Sardinia differs from that in the general population. Journal of Pediatric Endocrinology & Metabolism. 2001; 14: 781-783.
34) A. Loviselli, F. Velluzzi, P. Mossa, M. A. Cambosu, G. Secci, F. Atzeni, A. Taberlet, A. Balestrieri, E. Martino, L. Grasso, M. Songini, G. F. Bottazzo, S. Mariotti, and the Sardinian Schoolchildren Study Group. The Sardinian Autoimmunity Study: 3. Studies on Circulating Antithyroid Antibodies in Sardinian Schoolchildren: Relationship to Goiter Prevalence and Thyroid Function. Thyroid. 2001; 11: 9: 849-857.
35) B. Idizor-Walus, M. B. Mattockt, B. Solnica, L Stevens, J. H. Fuller and the EURODIAB IDDM Complications Study Group. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabetic Medicine 2001; 18: 786-796.
36) M. Toeller, AE Buyken, G. Heitkamp, G. Cathelineau, B. Ferriss, G. Michel and the EURODIAB IDDM Complications Study Group. Nutrient intakes as predictors of body weight in European people with type 1 diabetes.International journal of Obesity 2001; 25: 1815-1822.
37) A. Green, C. C. Patterson on behalf of the EURODIAB TIGER Study Group. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 2001; 44 (suppl 3): B3-B8.
38) C. C.Patterson, G. Dahlquist, G. Soltész, A. Green on behalf of the EURODIAB ACE Study Group. Is childhood-onset Type 1 diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia 2001; 44 (suppl 3): B9-B16.
39) K. S. Ronningen, N. Keiding, A. Green on behalf of Genomic Marker Contributors and the EURODIAB ACE Study Group. Correlations between the incidence of childhood-onset Type 1 diabetes in Europe and HLA genotypes. Diabetologia 2001; 44 (suppl 3): B51-B59.
40) P.A. Mckinney on behalf of the EURODIAB Seasonality of Birth Group. Seasonality of birth in patients with childhood Type 1 diabetes in 19 European regions.
Diabetologia 2001; 44 (suppl 3): B67-B74.
41) G. Lévy-Marchal, C. C. Patterson, A. Green on behalf of the EURODIAB ACE Study Group. Geographical variation of presentation at diagnosis of Type 1 diabetes in children: the EURODIAB Study.Diabetologia 2001; 44 (suppl 3): B75-B80.
42) M. Porta, A-K. Sjoelie, N. Chaturvedi, L. Stevens, R. Rottiers, M. Veglio, J. H. Fuller and the EURODIAB Prospective Complications Study Group. Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia 2001; 44: 2203-2209.
43) The Eurodiab IDDM Complications Study Group. Prevalence of Q-T Interval Dispersion in Type 1 Diabetes and Its Relation with Cardiac Ischemia. Diabetes Care 2002 ; 25: 702-707.
44) S. S. Soedamah-Muthu, H. M. Colhoun, H. Abrahamian, N. N. Chan, R. Mangili, G. P. Reboldi, J. H. Fuller, the EURODIAB Prospective Complications Study Group. Trends in hypertensionmanagement in type I diabetes across Europe, 1989/1990-1997/1999.Diabetologia 2002; 45: 1362-1371.
45) D. Bruttomesso, A. Tiengo.Continuous subcutaneous insulin infusion in Italy. Infusystems International 2002; 1 n°1: 5-8.
46) The Eurodiab Prospective Complications Study. Circulating and Urinary Transforming Growth Factor β1, Amadori Albumin, and Complications of type 1 Diabetes.Diabetes Care 2002; 25: 2320-2327.
47) P. Kempler, S. Tesfaye, N. Chaturvedit, L. K. Stevenst, D. J. Webbt,S. Eaton, Zs.Kerènyi, Gy. Tamàs, J. D. Ward, J. H. Fullert and the EURODIAB IDDM Complications Study Groups. Autonomic neuropathy is associatedwith increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabetic Medicine 2002; 19: 900-909.
48) Janice S. Dorman, Ann R. Steenkiste, James P. Burke, Marco Songini. Type 1 Diabetes and Multiple Sclerosis. Diabetes Care 2003;26:113192-3193.
49) The Eurodiab Prospective Complications Study. Vascular Risk Factors and Markers of Endothelial Function as Determinants of Inflammatory Markers inType 1 Diabetes. Diabetes Care 2003;26(7):2165-2173.
50) Schram MT, Chaturvedi N, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group. Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study. J Hypertens 2003;21(11):2035-44.
51) Schram MT, Chaturvedi N, Schalkwijk C, GiorginoF, Ebeling P, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.Diabetes Care 2003;(7):2165-73.
52) A. Casu, C. Pascutto, L. Bernardinelli and M. Songini. Bayesian approach to study the temporal trend and the geographical variation in the risk of type 1 diabetes. The Sardinian Conscript Type 1 Diabetes Registry. Pediatric Diabetes 2004;5:32-38.
53) Kyvik KO, Nystrom L, Gorus F, Songini M, Oestman J, Castell C, Green A, Guyrus E, Ionescu-Tirgoviste C, McKinney PA, Michalkova D, Ostrauskas R, RaymondNT. The epidemiology of Type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 2004;47(3):377-84
54) Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N. Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 2004;47(6):1020-8.
55) Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, Manes C, Fuller JH; EURODIAB Prospective Complications Study Group. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care. 2004;27(2):530-7.
56) A. Casu, C. Pascutto, L. Bernardinelli, The Sardinian IDDM Epidemiology Study Group, M. Songini. Type 1 Diabetes Among Sardinian Children Is Increasing. Diabetes Care 2004;27(7):1623-29.

Back to top